Publicacions
-
Nailor A, Walker, DA, Jacques, TS, Warren, KE, Brem, H, Kearns, PR, Greenwood, J, Penny, JI, Pilkington, GJ, Carcaboso AM, Fleischhack, G, Macarthur, D, Slavc, I, Meijer, L, Gill, S, Lowis, S, van Vuurden, DG, Pearl, MS, Clifford, SC, Morrissy, S, Ivanov, DP, Beccaria, K, Gilbertson, RJ, Straathof, K, Green, JJ, Smith, S, Rahman, R and Kilday, JP.
Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain Tumours.
ecancermedicalscience . 10: 630-630. Nº de cites: 2
-
Rosé A, André N, Rozados VR, Mainetti LE, Márquez MM, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Mora J, García WG, Epelman S, Alasino C, Alonso D, Chantada G and Scharovsky OG.
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.
ecancermedicalscience . 10: 672-672. Nº de cites: 10
-
Daryani VM, Patel YT, Tagen M, Turner DC, Carcaboso AM, Atkinson JM, Gajjar A, Gilbertson RJ, Wright KD and Stewart CF.
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma.
CPT: pharmacometrics & systems pharmacology . 5(4): 211-221. Nº de cites: 6
-
Paco-Mercader S, Casserras T, Rodríguez-García MA, Jou-Munoz C, Puigdelloses M, Ortez-Gonzalez CI, Diaz-Manera J, Gallardo E, Colomer J, Nascimento-Osorio A, Kalko SG and Jimenez-Mallebrera C.
Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators
PLoS One . 10(12): . Nº de cites: 21
-
Garzón M, García-Fructuoso G, Suñol M, Mora J and Cruz-Martínez O.
Low-grade gliomas in children: single institutional experience in 198 cases
CHILDS NERVOUS SYSTEM . 31(9): 1447-1459. Nº de cites: 8
-
Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.
Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts
PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de cites: 10
-
Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, Del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pastó G, San-Segundo L, Vilà-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J and de Álava E.
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Oncotarget . 6(22): 18875-18890. Nº de cites: 64
-
Piquer-Gibert M, Alsina L, Giner MT, Cruz-Martínez O, Ruiz Echevarria K, Domínguez-Sánchez O, Plaza-Martín AM, Arostegui JI, de Valles G, Juan Otero M and Martín-Mateos MA.
Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency
EUROPEAN JOURNAL OF PEDIATRICS . 174(8): 1069-1076. Nº de cites: 19
-
Morales-La Madrid A, Hashizume R and Kieran MW.
Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic.
Frontiers in oncology . 5: 148-148. Nº de cites: 40
-
Mora J, Cruz-Martínez O, Lavarino C, Rios J, Vancells M, Parareda A, Salvador-Hernandez H, Suñol M, Carrasco-Torrents R, Guillen-Quesada A, Mañé S and de Torres C.
Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)
CLINICAL & TRANSLATIONAL ONCOLOGY . 17(7): 521-529. Nº de cites: 12